FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2342924512> ?p ?o ?g. }

• W2342924512 endingPage "1483" @default.
• W2342924512 startingPage "1478" @default.
• W2342924512 abstract "Ewing's sarcoma is a devastating rare pediatric cancer of the bone. Intense chemotherapy temporarily controls disease in most patients at presentation but has limited effect in patients with progressive or recurrent disease. We previously described preliminary results of a novel immunotherapy, FANG (Vigil) vaccine, in which 12 advanced stage Ewing's patients were safely treated and went on to achieve a predicted immune response (IFNγ ELISPOT). We describe follow-up through year 3 of a prospective, nonrandomized study comparing an expanded group of Vigil-treated advanced disease Ewing's sarcoma patients (n = 16) with a contemporaneous group of Ewing's sarcoma patients (n = 14) not treated with Vigil. Long-term follow-up results show a survival benefit without evidence of significant toxicity (no ≥ grade 3) to Vigil when administered once monthly by intradermal injection (1 × 10e(6) cells/injection to 1 × 10e(7) cells/injection). Specifically, we report a 1-year actual survival of 73% for Vigil-treated patients compared to 23% in those not treated with Vigil. In addition, there was a 17.2-month difference in overall survival (OS; Kaplan-Meier) between the Vigil (median OS 731 days) and no Vigil patient groups (median OS 207 days). In conclusion, these results supply the rational for further testing of Vigil in advanced stage Ewing's sarcoma." @default.
• W2342924512 created "2016-06-24" @default.
• W2342924512 creator A5000323037 @default.
• W2342924512 creator A5002951950 @default.
• W2342924512 creator A5013695327 @default.
• W2342924512 creator A5015591858 @default.
• W2342924512 creator A5020525215 @default.
• W2342924512 creator A5039098373 @default.
• W2342924512 creator A5046995957 @default.
• W2342924512 creator A5052040011 @default.
• W2342924512 creator A5055054082 @default.
• W2342924512 creator A5065653743 @default.
• W2342924512 creator A5088629605 @default.
• W2342924512 date "2016-08-01" @default.
• W2342924512 modified "2023-10-16" @default.
• W2342924512 title "Three-year Follow up of GMCSF/bi-shRNA furin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma" @default.
• W2342924512 cites W1505048261 @default.
• W2342924512 cites W1592041923 @default.
• W2342924512 cites W1935226228 @default.
• W2342924512 cites W1974090832 @default.
• W2342924512 cites W1975044418 @default.
• W2342924512 cites W1987657194 @default.
• W2342924512 cites W1991937882 @default.
• W2342924512 cites W2002925242 @default.
• W2342924512 cites W2007535339 @default.
• W2342924512 cites W2017552485 @default.
• W2342924512 cites W2034600493 @default.
• W2342924512 cites W2040275378 @default.
• W2342924512 cites W2046131550 @default.
• W2342924512 cites W2050470657 @default.
• W2342924512 cites W2066897402 @default.
• W2342924512 cites W2071919091 @default.
• W2342924512 cites W2072909107 @default.
• W2342924512 cites W2073965542 @default.
• W2342924512 cites W2084626518 @default.
• W2342924512 cites W2096882042 @default.
• W2342924512 cites W2103460784 @default.
• W2342924512 cites W2103758698 @default.
• W2342924512 cites W2109614376 @default.
• W2342924512 cites W2113154896 @default.
• W2342924512 cites W2118541332 @default.
• W2342924512 cites W2120332010 @default.
• W2342924512 cites W2129148702 @default.
• W2342924512 cites W2152457341 @default.
• W2342924512 cites W2163261709 @default.
• W2342924512 cites W2164559547 @default.
• W2342924512 cites W2321142363 @default.
• W2342924512 doi "https://doi.org/10.1038/mt.2016.86" @default.
• W2342924512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5023386" @default.
• W2342924512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28125796" @default.
• W2342924512 hasPublicationYear "2016" @default.
• W2342924512 type Work @default.
• W2342924512 sameAs 2342924512 @default.
• W2342924512 citedByCount "68" @default.
• W2342924512 countsByYear W23429245122016 @default.
• W2342924512 countsByYear W23429245122017 @default.
• W2342924512 countsByYear W23429245122018 @default.
• W2342924512 countsByYear W23429245122019 @default.
• W2342924512 countsByYear W23429245122020 @default.
• W2342924512 countsByYear W23429245122021 @default.
• W2342924512 countsByYear W23429245122022 @default.
• W2342924512 countsByYear W23429245122023 @default.
• W2342924512 crossrefType "journal-article" @default.
• W2342924512 hasAuthorship W2342924512A5000323037 @default.
• W2342924512 hasAuthorship W2342924512A5002951950 @default.
• W2342924512 hasAuthorship W2342924512A5013695327 @default.
• W2342924512 hasAuthorship W2342924512A5015591858 @default.
• W2342924512 hasAuthorship W2342924512A5020525215 @default.
• W2342924512 hasAuthorship W2342924512A5039098373 @default.
• W2342924512 hasAuthorship W2342924512A5046995957 @default.
• W2342924512 hasAuthorship W2342924512A5052040011 @default.
• W2342924512 hasAuthorship W2342924512A5055054082 @default.
• W2342924512 hasAuthorship W2342924512A5065653743 @default.
• W2342924512 hasAuthorship W2342924512A5088629605 @default.
• W2342924512 hasBestOaLocation W23429245121 @default.
• W2342924512 hasConcept C121608353 @default.
• W2342924512 hasConcept C126322002 @default.
• W2342924512 hasConcept C141071460 @default.
• W2342924512 hasConcept C142724271 @default.
• W2342924512 hasConcept C143998085 @default.
• W2342924512 hasConcept C166957645 @default.
• W2342924512 hasConcept C2776694085 @default.
• W2342924512 hasConcept C2777586341 @default.
• W2342924512 hasConcept C2777701055 @default.
• W2342924512 hasConcept C2778256501 @default.
• W2342924512 hasConcept C2778447413 @default.
• W2342924512 hasConcept C71924100 @default.
• W2342924512 hasConcept C90924648 @default.
• W2342924512 hasConcept C95457728 @default.
• W2342924512 hasConceptScore W2342924512C121608353 @default.
• W2342924512 hasConceptScore W2342924512C126322002 @default.
• W2342924512 hasConceptScore W2342924512C141071460 @default.
• W2342924512 hasConceptScore W2342924512C142724271 @default.
• W2342924512 hasConceptScore W2342924512C143998085 @default.
• W2342924512 hasConceptScore W2342924512C166957645 @default.
• W2342924512 hasConceptScore W2342924512C2776694085 @default.
• W2342924512 hasConceptScore W2342924512C2777586341 @default.
• W2342924512 hasConceptScore W2342924512C2777701055 @default.

• next